trending Market Intelligence /marketintelligence/en/news-insights/trending/q9IIVpCc0UNVIa9yv7uRcg2 content esgSubNav
In This List

RXi Pharmaceuticals names board member

Blog

Insight Weekly: US bank stress tests; cracks in housing market; summer energy supply risks

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches


RXi Pharmaceuticals names board member

RXi Pharmaceuticals Corp. appointed Jonathan Freeman to its board as an independent director, with immediate effect.

Freeman also serves as the chief business officer of privately held Vedanta Biosciences.